Syndecan-4 negatively regulates antiviral signalling by mediating RIG-I deubiquitination via CYLD

Wei Lin, Jing Zhang, Haiyan Lin, Zexing Li, Xiaofeng Sun, Xin Di, Meng Yang, Liwei Sun, Lin Li, Hongmei Wang, Dahua Chen, Qinmiao SunNature Communications 2016 · DOI

Abstract

Retinoic acid-inducible gene I (RIG-I) plays important roles in pathogen recognition and antiviral signalling transduction. Here we show that syndecan-4 (SDC4) is a RIG-I-interacting partner identified in a yeast two-hybrid screen. We find that SDC4 negatively regulates the RIG-I-mediated antiviral signalling in a feedback-loop control manner. The genetic evidence obtained by using knockout mice further emphasizes this biological role of SDC4 in antiviral signalling. Mechanistically, we show that SDC4 interacts with both RIG-I and deubiquitinase CYLD via its carboxyl-terminal intracellular region. SDC4 likely promotes redistribution of RIG-I and CYLD in a perinuclear pattern post viral infection, and thus enhances the RIG-I-CYLD interaction and potentiates the K63-linked deubiquitination of RIG-I. Collectively, our findings uncover a mechanism by which SDC4 antagonizes the activation of RIG-I in a CYLD-mediated deubiquitination-dependent process, thereby balancing antiviral signalling to avoid deleterious effects on host cells.

Introduction

In the innate immune system, the protein RIG-I (Retinoic acid-inducible gene I) serves as a primary sensor for viral RNA. Upon detection, RIG-I is activated through K63-linked ubiquitination, triggering the production of Type I interferons (IFNs) and initiating an antiviral state. However, to prevent chronic inflammation or autoimmunity, this potent signaling pathway must be tightly regulated. This study identifies Syndecan-4 (SDC4) as a critical "off-switch" that facilitates the deactivation of RIG-I via a feedback-loop mechanism.

Results

Validation of the SDC4-RIG-I Interaction

Through a yeast two-hybrid screen and subsequent co-immunoprecipitation (Co-IP) assays, researchers confirmed that SDC4 physically interacts with the signaling domains of RIG-I. Notably, this interaction is significantly enhanced following infection with Sendai virus (SeV), suggesting that SDC4 acts as a feedback regulator that is recruited or activated during the peak of the antiviral response.

SDC4 interacts with RIG-I, and the interaction is enhanced upon Sendai virus (SeV) infection.

Spatial Regulation and Perinuclear Clustering

A key mechanistic insight of this study is the spatial redistribution of these proteins. Confocal microscopy revealed that while SDC4 and RIG-I are distributed throughout the cytoplasm in mock-infected cells, viral infection triggers their co-localization into a distinct perinuclear pattern. This clustering is thought to facilitate the recruitment of the deubiquitinase CYLD to the RIG-I complex, allowing for efficient removal of activating ubiquitin tags.

Confocal microscopy shows that SDC4 and RIG-I colocalize in the perinuclear region following SeV infection.

SDC4 as a Molecular Matchmaker

SDC4 does not possess intrinsic deubiquitinase activity. Instead, it functions as a molecular scaffold. Using its carboxyl-terminal intracellular region (CP domain), SDC4 brings RIG-I and CYLD together. Functional assays demonstrated that deleting this CP domain completely abolishes SDC4's ability to inhibit the antiviral response, highlighting its essential role in mediating the RIG-I-CYLD interaction.

Genetic Evidence and Enhanced Immunity

The biological significance of SDC4 was further validated using Sdc4 knockout (KO) mice. These mice exhibited significantly higher resistance to viral challenges, characterized by lower viral titers and increased survival rates compared to wild-type counterparts. In the absence of SDC4, RIG-I remained hyper-ubiquitinated, leading to a sustained and elevated production of antiviral cytokines like IFN-β and IL-6.

Discussion

This research highlights a sophisticated mechanism for maintaining immune homeostasis. By inducing SDC4 expression post-infection, the cell ensures that the RIG-I pathway is eventually dampened, protecting the host from the deleterious effects of overactive signaling.

Future work may explore SDC4 as a therapeutic target; inhibiting its function could potentially boost antiviral responses during acute infections, while enhancing its activity might offer a strategy for treating autoimmune disorders driven by aberrant RIG-I signaling. Additionally, understanding how SDC4 balances its known structural roles in cell adhesion with its newly discovered function in immune regulation remains an intriguing area for further study.

Summary updated

Abstract

Retinoic acid-inducible gene I (RIG-I) plays important roles in pathogen recognition and antiviral signalling transduction. Here we show that syndecan-4 (SDC4) is a RIG-I-interacting partner identified in a yeast two-hybrid screen. We find that SDC4 negatively regulates the RIG-I-mediated antiviral signalling in a feedback-loop control manner. The genetic evidence obtained by using knockout mice further emphasizes this biological role of SDC4 in antiviral signalling. Mechanistically, we show that SDC4 interacts with both RIG-I and deubiquitinase CYLD via its carboxyl-terminal intracellular region. SDC4 likely promotes redistribution of RIG-I and CYLD in a perinuclear pattern post viral infection, and thus enhances the RIG-I-CYLD interaction and potentiates the K63-linked deubiquitination of RIG-I. Collectively, our findings uncover a mechanism by which SDC4 antagonizes the activation of RIG-I in a CYLD-mediated deubiquitination-dependent process, thereby balancing antiviral signalling to avoid deleterious effects on host cells.
BibTeX
@inproceedings{lin2016syndecan,
  author = {Wei Lin and Jing Zhang and Haiyan Lin and Zexing Li and Xiaofeng Sun and Xin Di and Meng Yang and Liwei Sun and Lin Li and Hongmei Wang and Dahua Chen and Qinmiao Sun},
  title = {{Syndecan-4 negatively regulates antiviral signalling by mediating RIG-I deubiquitination via CYLD}},
  booktitle = {Nature Communications},
  year = {2016},
  doi = {10.1038/ncomms11848},
}

Loading related content...

Figure